Shaweta Sharma, Prateek Singh, P. Sharma, Aftab Alam
{"title":"Drug Polymorphism: An Important Pre-formulation Tool in the Formulation Development of a Dosage Form","authors":"Shaweta Sharma, Prateek Singh, P. Sharma, Aftab Alam","doi":"10.2174/1877946813666230822113606","DOIUrl":null,"url":null,"abstract":"\n\nPolymorphism permits solids to have two or multiple crystal structures with varying orientations or conformations, and polymorph drug dissolution and solubility vary. Polymorphism influences drug efficacy, bioavailability and toxicity. Various parameters can regulate polymorph crystallization, including supersaturation phase, temperature, stirring rate, solvent addition rate, seed crystal, additives and pH. To characterize and monitor polymorphs, various analytical approaches are available, including powder X-Ray diffraction / X-Ray diffraction (PXRD/XRD), also called as Gold Standard method, differential scanning calorimetry (DSC), Infrared spectroscopy (IR), and microscopical studies. To prevent polymorphic change during production, distribution, and storage, formulation with the most stable form in the marketed product is considered. In addition, by monitoring each phase of raw material processing, polymorphisms can be controlled during dosage form manufacturing. \nThe objective of this review is to provide concise information on drug polymorphism, their characterization process, their effect on the stability of dosage forms, factors controlling polymorphism in the crystallization process, some case studies on polymorphs, control of polymorphism during the formulation of successful dosage forms and some of the regulatory considerations regarding polymorphs.\nVarious databases like Pubmed/Medline, Google Scholar and Web of Science of all English language articles were searched, and relevant information was collected regarding the importance of polymorphism in formulation development.\nFrom a vast literature survey, it was found that polymorphism is a very important tool in a pre-formulation study that provides information about the fate of a drug molecule in its journey.\nFrom the present study, it was concluded that the polymorphism property of a drug should be taken into consideration at the pre-formulation stage since it is a very important tool for the formulation of a successful dosage form with stability and efficacy.\n","PeriodicalId":89671,"journal":{"name":"Current physical chemistry","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current physical chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1877946813666230822113606","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Polymorphism permits solids to have two or multiple crystal structures with varying orientations or conformations, and polymorph drug dissolution and solubility vary. Polymorphism influences drug efficacy, bioavailability and toxicity. Various parameters can regulate polymorph crystallization, including supersaturation phase, temperature, stirring rate, solvent addition rate, seed crystal, additives and pH. To characterize and monitor polymorphs, various analytical approaches are available, including powder X-Ray diffraction / X-Ray diffraction (PXRD/XRD), also called as Gold Standard method, differential scanning calorimetry (DSC), Infrared spectroscopy (IR), and microscopical studies. To prevent polymorphic change during production, distribution, and storage, formulation with the most stable form in the marketed product is considered. In addition, by monitoring each phase of raw material processing, polymorphisms can be controlled during dosage form manufacturing.
The objective of this review is to provide concise information on drug polymorphism, their characterization process, their effect on the stability of dosage forms, factors controlling polymorphism in the crystallization process, some case studies on polymorphs, control of polymorphism during the formulation of successful dosage forms and some of the regulatory considerations regarding polymorphs.
Various databases like Pubmed/Medline, Google Scholar and Web of Science of all English language articles were searched, and relevant information was collected regarding the importance of polymorphism in formulation development.
From a vast literature survey, it was found that polymorphism is a very important tool in a pre-formulation study that provides information about the fate of a drug molecule in its journey.
From the present study, it was concluded that the polymorphism property of a drug should be taken into consideration at the pre-formulation stage since it is a very important tool for the formulation of a successful dosage form with stability and efficacy.
多晶型允许固体具有两种或多种不同取向或构象的晶体结构,多晶型药物溶出度和溶解度各不相同。多态性影响药物的疗效、生物利用度和毒性。各种参数可以调节多晶的结晶,包括过饱和相、温度、搅拌速率、溶剂加入速率、种子晶体、添加剂和ph。为了表征和监测多晶,有各种分析方法可用,包括粉末x射线衍射/ x射线衍射(PXRD/XRD),也称为金标准法,差示扫描量热法(DSC),红外光谱(IR)和显微研究。为了防止在生产、分销和储存过程中发生多态性变化,应考虑在上市产品中使用最稳定形式的配方。此外,通过监测原料加工的每个阶段,可以在剂型制造过程中控制多态性。本文综述了药物多晶型及其表征过程、对剂型稳定性的影响、结晶过程中控制多晶型的因素、多晶型的一些案例研究、成功剂型的制备过程中对多晶型的控制以及有关多晶型的一些监管注意事项。检索所有英文文章的Pubmed/Medline、谷歌Scholar和Web of Science等数据库,收集多态性在制剂开发中的重要性的相关信息。从大量的文献调查中,我们发现多态性在制剂前研究中是一个非常重要的工具,它提供了药物分子在其旅程中的命运信息。从本研究得出结论,药物的多态性特性是制备稳定有效的成功剂型的重要工具,应在制剂前阶段加以考虑。